SCHEMBL6654431

SCHEMBL6654431

Cc1oc2cccc(N)c2c1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD44 P16070 1/20 0.43
CYP3A4 P08684 4/20 0.42
TSHR P16473 2/20 0.42
PIK3CA P42336 1/20 0.42
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
ALDH1A1 P00352 6/20 0.35
TDP1 Q9NUW8 2/20 0.34
KDM4E B2RXH2 4/20 0.33
HPGD P15428 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPT P10636 2/20 0.33
ELANE P08246 1/20 0.33
GAA P10253 2/20 0.33
NSD2 O96028 1/20 0.33
CASP6 P55212 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.32
ALOX15 P16050 1/20 0.32
CASP1 P29466 1/20 0.32
CASP7 P55210 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21665556 0.83 CYP3A4 (0.48) CD44CYP3A4TSHRPIK3CAESR1
SCHEMBL22289608 0.83 CD44 (0.43) CD44CYP3A4TSHRPIK3CAALDH1A1
SCHEMBL10756036 0.76 CYP3A4 (0.41) CD44CYP3A4TSHRPIK3CAESR1
SCHEMBL3872856 0.76 ALDH1A1 (0.43) CD44CYP3A4TSHRPIK3CAESR1
SCHEMBL22333730 0.75 CYP3A4 (0.35) CD44CYP3A4TSHRPIK3CAESR1
SCHEMBL19142155 0.74 CD44 (0.48) CD44CYP3A4TSHRPIK3CAESR1
SCHEMBL6659211 0.74 ESR1 (0.37) CD44CYP3A4TSHRPIK3CAESR1
SCHEMBL17994122 0.71 KDM4E (0.55) CYP3A4ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL4922420 0.68 NQO1 (0.52) CYP3A4TSHRESR1ESR2ALDH1A1
SCHEMBL19233666 0.68 KDM4E (0.43) ALDH1A1KDM4EHPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040231067-A1 Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses L'OREAL (FR) 2004-11-25 US claimed
EP-1428510-A1 Dyeing composition comprising a tertiary paraphenylenediamine containing a pyrrolidine, and a heterocyclic coupler or a hydroxybenzamide ; method and use L'OREAL (FR) 2004-06-16 EP claimed
EP-1428510-A1 Dyeing composition comprising a tertiary paraphenylenediamine containing a pyrrolidine, and a heterocyclic coupler or a hydroxybenzamide ; method and use L'OREAL (FR) 2004-06-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040231067-A1 Dyeing composition comprising a cationic tertiary para-phenylenediamine and heterocyclic coupler, methods and uses KRT18, CDC73, PYCR1 CD44 1672/4885CYP3A4 1290/4885TSHR 2538/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.